Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of PsASon ultrasound scores in psoriatic arthritis patients treated with Apremilast
2018-001758-89Phase 4Terminated
- Sponsor
- Medical University of Graz
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of apremilast in psoriatic arthritis (PsA), sponsored by Medical University of Graz. Started May 2019; status: terminated.
02
Drugs
apremilast
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2018-001758-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001758-89.